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PELD (Progressive Encephalopathy with or without Lipodystrophy or Celia’s Encephalopa-
thy) is a fatal and rare neurodegenerative syndrome associated with the BSCL2mutation
c.985C>T, that results in an aberrant transcript without the exon 7 (Celia seipin). The aim of
this study was to evaluate both the process of cellular senescence and the effect of unsatu-
rated fatty acids on preadipocytes from a homozygous c.985C>T patient. Also, the role of
aberrant seipin isoform on adipogenesis was studied in adipose-derived human mesenchy-
mal stem cells.
Material and methods
Cellular senescence was evaluated using β-galactosidase staining of preadipocytes
obtained from a homozygous c.985C>T patient. Moreover, these cells were cultured during
24 hours with Intralipid, a soybean oil-based commercial lipid emulsion. The expression of
the different BSCL2 transcripts was measured by qPCR. Adipose-derived human mesen-
chymal stem cells were differentiated to a fat lineage using StemPRO adipogenesis kit, and
the expression of BSCL2 transcripts and several adipogenesis-related genes was mea-
sured by qPCR.
Results
the treatment of preadipocytes with unsaturated fatty acids significantly reduced the expres-
sion of the BSCL2 transcript without exon 7 by 34 to 63%. On the other hand, at least in pre-
adipocytes, this mutation does not disturb cellular senescence rate. Finally, during
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adipocyte differentiation of adipose-derived human mesenchymal stem cells, the expres-
sion of adipogenic genes (PPARG, LPIN1, and LPL) increased significantly over 14 days,
and noteworthy is that the BSCL2 transcript without exon 7 was differentially expressed by
332 to 723% when compared to day 0, suggesting an underlying role in adipogenesis.
Conclusions
our results suggest that Celia seipin is probably playing an underestimated role in adipocyte
maturation, but not in senescence, and its expression can be modified by exogenous fac-
tors as fatty acids.
Introduction
Seipin is a protein whose function has not been yet fully elucidated. Mutations in BSCL2 gene
are related to type 2 Berardinelli-Seip congenital lipodystrophy (type 2 CGL) [1] and also with
various congenital neuropathies [2]. Seipin is a membrane protein of the endoplasmic reticulum
(ER). Predictive algorithms and experimental data suggest that it consists of two transmembrane
domains, a highly conserved intraluminal loop, and two N-terminal and C-terminal domains in
cytoplasm [3].
Under natural conditions, BSCL2 gene encodes mainly three transcripts of 462 (BSCL2-003,
ENST00000360796; CCDS44627), 398 (BSCL2-004/005/006, ENST00000421906; ENST00000407022;
ENST00000403550; CCDS8031) and 287 (BSCL2-008, ENST00000278893; CCDS55769) amino
acids respectively. The first transcript described [1] was BSCL2-004/005/006. BSCL2-003 is identi-
cal to the first one except for a N-terminal extension of 64 amino acids encoded by exon 1. The
287-amino acid short transcript features skipping of exon 7, which results in a change in the
reading frame, so that the resulting protein is completely different from the other two ones in the
amino acid stretch encoded from exon 6 to exon 10.
The function of seipin is still being investigated, however, its relationship with adipogenesis,
with the genesis of lipid droplets and the regulation of the metabolism of phospholipids and
triacylglycerides has been established [4–10]. It was also suggested that seipin might play an
important role in the nervous system [11–15].
Type 2 CGL syndrome is a rare autosomal recessive disease characterized by an almost total
lack of adipose tissue in the body. In addition to the lack of adipose tissue, other clinical fea-
tures are insulin resistance, liver steatosis and hypertriglyceridemia, which can evolve into dia-
betes mellitus and early cirrhosis. Type 2 CGL is also characterized by a cognitive delay of
variable severity [16]. Moreover, BSCL2-associated neuropathies are autosomal dominant dis-
orders affecting upper and/or low motor neuron without affecting life expectancy.
We have previously reported a new seipin-associated neurodegenerative syndrome (PELD,
Progressive Encephalopathy with/without Lipodystrophy or Celia’s Encephalopathy, MIM:
#615924) [17] due to a c.985C>Tmutation in BSCL2 gene. This mutation gives rise to an alter-
native splicing leading to skipping of exon 7 and a reading frame shift resulting in a new aberrant
protein, hereafter called Celia seipin [17], similar to BSCL2-008 transcript. Patients suffering
PELD die prematurely before age 9 as a consequence of a severe and progressive encephalopathy.
Noteworthy, homozygous cases hardly show lipodystrophic features while compound heterozy-
gous cases have a mixed phenotype, neurodegenerative and lipodystrophic.
Despite its recessive pattern of inheritance, we have proposed a toxic gain of function mech-
anism, so that Celia seipin accumulation in the ER of neurons might induce the unfolded pro-
tein response (UPR) responsible for cellular damage and apoptosis [17, 18].
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A relevant fact in the natural history of this neurodegenerative condition is that neurological
clinical signs do not appear immediately. Thus, affected children are born healthy from a neu-
rological point of view. The homozygous patients manifest psychomotor delay between 12 and
24 months of age and neurological involution becomes evident after 3 years. In compound het-
erozygotes, lipodystrophy was evident from the first month of life, while the neurological natu-
ral history was similar to the homozygous cases. All patients died between 7–8 years, except the
youngest one, who is still, at 6.8 years of age, in the early stages of the neurological condition.
Given this striking disease evolution, we wondered whether c.985C>T mutation could inter-
fere in the process of cellular senescence. In this line, in vitro studies with yeast, have shown the
importance of a correct lipolysis for the progression of the cell cycle [19], and mutations in
FLD1, the orthologous gene of BSCL2, decreases lipolysis [10], suggesting a possible molecular
relationship with cellular senescence.
On the other hand, all these patients, both homozygous and compound heterozygous, pre-
sented, at least during the first months of life, very high levels of plasma triglycerides. It is well
known [20] that the contribution of essential fatty acids is key for a normal development of the
nervous system in humans, mainly up to 3 years of age, and, as already mentioned, seipin plays
a crucial role in the formation of lipid droplets and in the synthesis of phospholipids [4, 5, 7,
21]. Therefore, another hypothesis of this study is that the contribution of fatty acids in the diet
might influence the disease evolution of this neurodegenerative process.
In addition, previous studies of our group suggest that BSCL2-008 transcript might play a
positive role in the maintenance of adipogenesis, considering that clinical features of type 2
CGL revert or are not present in homozygous subjects for the c.985C>T mutation [17]. Since
no relation between short human BSCL2 transcript and adipogenesis has been established
before, this led us to study the involvement of BSCL2 transcripts during the differentiation of
adipose-derived human mesenchymal stem cells (ADSCs).
Materials and Methods
This study was approved by the Ethics Review Panel of Xunta de Galicia, and carried out
according to the ethical guidelines of the Helsinki Declaration. Written informed consent was
obtained from the parents of the participants included in the study.
Adipose tissue biopsies and cell culture
A small sample of subcutaneous adipose tissue of the abdominal area was obtained from the
index case (homozygous for c.985C>T mutation), at 6 years of age. A control adipose tissue
sample was obtained, in accordance with ethical regulations of current Spanish legislation,
from a 6-year-old control boy who underwent programmed abdominal surgery for cryptorchi-
dism. The collected explants were processed immediately following sampling. Small pieces of
adipose tissue were rinsed with PBS and placed on a 60 mm dish (BD FalconTM; Mississauga,
ON, Canada) containing Dulbecco’s modified Eagle’s medium (DMEM; Sigma-Aldrich,
St. Louis, MO, USA) plus 30% fetal bovine serum (FBS) and gentamicin 50 μg/mL (Sigma-
Aldrich), and incubated at 37°C with 5% CO2 in a Water-Jacket CO2 incubator (NuAire, Plym-
outh, MN, USA). After one week, preadipocytes that had migrated out of the explants were rec-
ognized by the presence of small lipid droplets within the fibroblast-like cells. The explants
tissues were then removed from the dishes and the cells were further cultured with fresh
medium until a 70% confluent monolayer was obtained. Afterwards, these preadipocytes were
tripsinized (TrypLE™ Express Stable Trypsin-like Enzyme with Phenol Red; Gibco Life Tech-
nologies; Carlsbad, CA, USA) and cultured on 100 mm dishes in DMEM containing 10% FBS
and penicillin-streptomycin 1% (Sigma-Aldrich). Commercially available ADSCs were
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purchased from Invitrogen (StemPro human adipose-derived stem cells, Invitrogen, Carlsbad,
CA, USA). Invitrogen isolated these ADSCs from the abdominal region of a 39-year-old female
donor using lipoaspirate, the cells were then expanded for one passage prior to cryopreserva-
tion and assayed for purity using flow cytometric analysis of cell surface antigen expression.
ADSCs were maintained in tissue culture grade uncoated Petri dishes (BD FalconTM) in com-
plete MesenPRO RS™medium (Invitrogen) supplemented with 1x GlutaMAX™-I (Gibco) and
gentamicin 50 μg/mL, and incubated at 37°C with 5% CO2 in a Water-Jacket CO2 incubator
(NuAire). Culture medium was changed every three days, and the cells were split at 80% con-
fluence. ADSCs were used at low-passage 3 for all experiments.
Treatment with fatty acids
Preadipocytes were cultured on 35 mmmultiwell dishes (6-well plates) in DMEM containing
10% FBS and penicillin-streptomycin 1% supplemented during 24 hours with 83.3 mg/dL
Intralipid (200 mg/mL, Fresenius Kabi, Uppsala, Sweden), a soybean oil-based commercial
lipid emulsion that is enriched predominantly with polyunsaturated fatty acids (PUFA: 61%);
specifically, the fatty acid composition of Intralipid is 54.7% linoleic, 20.9% oleic, 11% palmitic,
6.6% alpha-linolenic and 3.9% stearic [22]. The dose was chosen in agreement to that used in
human parenteral nutrition assuming a distribution volume of 5 L.
Senescence associated β-galactosidase staining
Expression of pH-dependent senescence associated β-galactosidase (SA-β-gal) activity was ana-
lyzed simultaneously in different passages of control and index case preadipocytes using the
SA-β-gal staining kit (Cell Signaling Technology, Boston, MA) [23]. Cells were cultured in
24-well plates (6.5 mmmultiwell dishes) during 24 hours, washed in PBS, fixed for 15 minutes
at room temperature in 2% formaldehyde/0.2% glutaraldehyde, washed again, and incubated
overnight at 37°C (without CO2) with fresh staining solution: 1 mg/mL of 5-bromo-4-chloro-
3-indolyl β-D-galactoside (X-Gal) in dimethylformamide, 40 mM citric acid/sodium phos-
phate, pH 6.0, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 150 mMNaCl, 2
mMMgCl2. Cell nuclei were stained with 5 μl/well of 50 μM fluorochrome bisbenzamide
(Hoechst 33258; Santa Cruz Biotechnology, Santa Cruz, CA, USA) during 40 minutes at room
temperature. Cells were visualized with an Olympus IX51 microscope (Olympus Corporation,
Tokyo, Japan) by bright field microscopy and photographed with an Olympus DP72 digital
camera using the cellSens software (Olympus Corporation). Quantification was performed
with ImageJ software (National Institute of Mental Health) in triplicate, taking 4 random non-
overlapping fields of view for each sample.
Adipogenic differentiation and Oil Red O staining
To induce ADSCs adipogenic differentiation, culture medium was switched to a commercially
available differentiation media kit, StemPRO adipogenesis kit (Invitrogen). Culture medium
was changed every three days. At day 14 after induction of adipogenic differentiation, ADSCs
were stained with Oil Red O (Sigma-Aldrich) to reveal fully differentiated cells. Cells were
washed with PBS and fixed in 10% formalin in isotonic buffer for 1 hour at room temperature.
After rinsing three times with double distilled H2O to remove residual formalin, lipid vacuoles
were stained with 0.6% Oil Red O (weight/volume) in 60% isopropanol for 1 hour at 22°C and
washed three times with double distilled H2O. Following Oil Red O staining, cells were finally
visualized with an Olympus IX51 microscope (Olympus Corporation) and photographed with
an Olympus DP72 digital camera using the software cellSens (Olympus Corporation).
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RNA extraction and retrotranscription
Total RNA was extracted from preadipocytes and ADSCs using Trizol (Invitrogen) as per the
manufacturer’s instructions. RNA was reverse-transcribed using M-MLV reverse transcriptase
(Invitrogen) as previously described [24].
cDNA PCR
BSCL2 cDNA was amplified with primers designed with the Primer3Plus software (http://
www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi) (forward: 5’-CAGATGCTGGA
CACACTGGT-3’, reverse: 5’-ATCACTGGCCTCAGGCTCTA-3’). PCR conditions were as
follows: 5 min at 95°C followed by 40 cycles, each consisting of 30 s at 95°C, 30 s at 59°C, and 1
min at 72°C, then a 10 min final elongation at 72°C. Amplification fragments obtained were
separated out by agarose gel electrophoresis (1%).
Real-time RT-PCR
Specific primers and probes designed by Universal ProbeLibrary (Roche Diagnostics, Sant
Cugat del Valles, Spain) were used in a Light Cycler 2.0 (Roche Diagnostics) to determine spe-
cifically expression of adipogenic genes PPARG, LPIN1 and LPL, and two distinct BSCL2 tran-
scripts on days 0, 1, 2, 3, 4, 5, 6, 7, 8 and 14 of adipogenic differentiation. The probe #73
(TCCTCAGC) used with forward: 5’-TGCGCCTTCATAGGTGTTG-3’, and reverse primer:
5’-ACCCACTGCATGTAGCTGAA-3’, hybridizes with exon 7 of BSCL2 gen (amplicon 74
nucleotides), while the reverse primer: 5’-AGCGATCATTGAGATCCACA-3’, used with the
probe #42 (CATCCAGC) and forward primer: 5’-TTTTCGGATGTTAACCTGAGC-3’, exclu-
sively hybridizes with the union of exon 6 and exon 8 (amplicon 96 nucleotides). Real-time
RT-PCR conditions are available upon request. Results were normalized for the RNA polymer-
ase II or 18s rRNA genes using the 2-ΔΔ CT method [25].
Statistical Analysis
The statistical significance was determined using non-parametric Kruskal-Wallis test, followed
by a Mann-Whitney U post-hoc with Bonferroni correction. Senescence assay was performed
in triplicate, taking photographs of 4 random fields per well, and real-time RT-PCR analyses in
duplicate, n = 4. Data are presented as mean ± SD with statistical significance set at P<0.05. All
statistical analyses were performed using SPSS for PC (release 22.0; SPSS, Chicago, IL, USA).
Results
Exon 7 skipping confirmation
Preadipocytes from index case and control were cultured and analyzed by PCR to study the
expression of seipin. As shown in Fig 1A, control cells showed a single band in electrophoresis,
while the index case samples showed a second band of lower molecular weight, corresponding
to the exon 7 skipped Celia transcript, in agreement with our previous study [17]. Moreover,
this electrophoretic differential pattern remained identical at all passages. Similarly, after treat-
ment with Intralipid, the electrophoretic pattern did not change in the different passages of
both control and index case samples (Fig 1B).
Expression of seipin transcripts
The basal expression of the transcripts containing exon 7 was much higher (72-fold, passages
average) than that of the exon 7-skipped transcript in control cells, while this was not so in
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cells from the index case, in which the expression of the two transcripts was in a similar order
(Table 1A). At basal conditions and as expected, the relative expression of the large transcripts
was reduced in preadipocytes with the c.985C>T BSCL2 Celia mutation (13%) as compared
with control cells, however, the expression of the skipped transcript in mutant cells was around
10-17-fold higher than that was observed in control cells (Table 1A).
Regarding real time RT-PCR studies of control and index case preadipocytes, no significant
differences were detected in the relative expression of the transcripts containing exon 7 after
Fig 1. Amplification results of the splicing region.Results of the amplification of the 573 bp region of cDNA from preadipocytes from the index case and
control subject in different passages without Intralipid treatment (a) or in the presence of Intralipid (b). Only samples from the index case show the presence
of the 431 base pair-long additional band which once sequenced confirmed the skipping of exon 7.
doi:10.1371/journal.pone.0158874.g001
Table 1. Relative expression of BSCL2 transcripts.
A) Relative expression of BSCL2 transcripts at basal conditions
CONTROL INDEX CASE
With exon 7 Without exon 7 With exon 7 Without exon 7
P8 1.034±0.275 0.012±0.004 * 0.136±0.035 § 0.120±0.026 †
P12 1.036±0.302 0.017±0.005 * 0.164±0.028 § 0.282±0.062 † ‡ #
P15 1.109±0.321 0.016±0.006 * 0.172±0.051 § 0.195±0.059 †
B) Relative expression of BSCL2 transcripts after Intralipid treatment
CONTROL INDEX CASE
With exon 7 Without exon 7 With exon 7 Without exon 7
P8 1.096±0.214 0.013±0.002 * 0.101±0.017 § 0.079±0.011 †
P12 1.412±0.291 ‡ 0.012±0.002 * 0.142±0.030 § 0.102±0.029 †
P15 1.286±0.236 0.010±0.002 * 0.205±0.036 § ‡ 0.103±0.020 † ‡ #
Relative expression of BSCL2 transcripts referred to BSCL2 transcripts with exon 7 in control (A) at basal conditions, and (B) after Intralipid treatment:
skipped transcript referred to BSCL2 transcripts containing the exon 7 in control
*: P<0.05; skipped transcript referred to BSCL2 transcripts containing the exon 7 in index case
#: P<0.05; transcripts with exon 7 in index case referred to BSCL2 transcripts containing the exon 7 in control
§: P<0.05; skipped transcript in index case referred to BSCL2 skipped transcript in control
†: P<0.05
‡: P<0.05 vs. P8. P: passage. All samples were analyzed in duplicate, n = 4. Results were normalized for the RNA polymerase II gene.
doi:10.1371/journal.pone.0158874.t001
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Intralipid treatment nor in the control neither in the index case cells (Fig 2A, Table 1B), while
there were significant differences in the relative expression of the skipped transcript in the
index case preadipocytes (Fig 2B, Table 1B). Thus, an unsaturated fatty acid enriched medium
significantly reduced (-48% on average for the different passages) the expression of the tran-
script without exon 7.
Fig 2. Relative expression and percentage of change in expression of BSCL2 transcripts after Intralipid
treatment. (a) Percentage of change referred to the relative expression of BSCL2 transcripts with exon 7 and (b)
without exon 7, in WT and index case preadipocytes, normalized to the RNA polymerase II gene. White bar: WT;
black bar: index case. All samples were analyzed in duplicate, n = 4, *:P<0.05.
doi:10.1371/journal.pone.0158874.g002
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Senescence studies
The percentage of senescent cells was calculated throughout the different passages in order to
assess a possible relationship of seipin and the c.985C>T mutation with cellular senescence.
Senescent and total cells were counted using the β-galactosidase and Hoechst 33258 dyes,
respectively (Fig 3). Little SA-β-galactosidase activity was detected in control and index case
cells at P8 (P: passage, 3.9% and 3.4%, respectively), but the number of senescent cells increased
continuously and significantly through serial passages both in control and index case cells as
evidenced by increased levels of senescence-associated β-galactosidase activity (Fig 3), which
increased approximately 20-to 25-fold, accounting for 76–98% of all index case cells, and 23-to
29-fold, accounting for 78–99% of all control cells. This result was expected as continuous cell
division is known to promote replicative senescence of cells in vitro [26]. No significant differ-
ences between index case and control preadipocytes were seen when cells at the same passage
were compared (Fig 3).
Fig 3. Representative photographs of SA-β-gal activity in preadipocytes. Early and late passages preadipocytes of control (WT) and index case
(c.985C>T) were subjected to in situ SA-β-gal staining at pH 6 and examined by bright field microscopy. The nuclei were counterstained with Hoechst
33258. Senescent and total cells were quantified in triplicate with ImageJ software, taking 4 random non-overlapping fields of view for each sample.
Original magnification ×10.
doi:10.1371/journal.pone.0158874.g003
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Expression of adipogenic genes after ADSCs differentiation
Differentiation of ADSCs into adipocytes over 14 days led to accumulation of lipid droplets
that were stained positively by Oil red O (S1 Fig). Real time RT-PCR studies were used to deter-
minate the expression of BSCL2 transcripts and adipogenic genes (Fig 4). As expected, ADSCs
differentiation toward the adipogenic lineage induced significant increase in the expression
of genes related to adipogenesis: when referred to day 0, PPARG and LPIN1 increased
Fig 4. Percentage of change in expression ofBSCL2 transcripts and adipogenic genes. Percentage of change in expression of BSCL2
transcripts and adipogenic genes referred to day 0, (a) BSCL2with exon 7 (b) BSCL2without exon 7 (c) PPARG, (d) LPIN1, (e) LPL, in
ADSCs (differentiated over 14 days into adipocytes) normalized to the 18S gene. All samples were analyzed in duplicate, n = 4, *:P<0.05.
doi:10.1371/journal.pone.0158874.g004
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approximately 2-to 5-fold and 2-to 3-fold, respectively, while the expression of LPL, an early
marker of adipogenic differentiation, was much higher and increased 7-to 11500-fold (Fig 4C–
4E). The expression of the BSCL2 transcripts containing exon 7 did not change significantly
over differentiation, while large significant changes were observed with the BSCL2 skipped
transcript whose expression increased notably from 3-to 7-fold since day 7 when compared to
day 0 (Fig 4A and 4B).
Discussion
To date, only 6 patients with Celia’s Encephalopathy have been reported [17] representing a
unique and intriguing disease. Homozygous patients did not show lipodystrophy, whereas
compound heterozygous subjects had a mixed phenotype, lipodystrophic and neurological
[17]. On the other hand, homozygous patient for c.985C>T mutation showed hypertriglyceri-
demia and hepatic steatosis during their first months of life which were easily corrected with a
animal fat-free diet in few months. Although all of these patients suffered an early psycho-
motor delay, it was not until 3–4 years of age when these children started their neurological
involution leading them to die in the first decade of life.
Although the most parsimonious explanation for the neurological PELD natural history is a
progressive loss of neurons affecting first the most evolved brain areas, a putative role for envi-
ronmental factors should not be ruled out. On the other hand, there is no information about
the role of senescence in the pathogenesis of this disease.
It is well known that essential fatty acids have an important influence in normal brain devel-
opment. So, unsaturated fatty acids, are important in neurogenesis as they have been impli-
cated as critical nutritional factors for appropriate neural function and development [27–30].
Indeed, it was shown that a huge development takes place in the infant brain: an extensive
growth including vast axonal and dendritic arborization. Synapses are rich in ω-3 docosahexae-
noic acid (DHA), which is proven to be essential in dendritic complexity, neurite outgrowth
and neurotransmitter metabolism [30].
985C>T BSCL2mutation gives rise to an alternative splicing site, and in this study, treat-
ment with Intralipid significantly reduced its expression by half. Although, for obvious reasons,
our experiments were not conducted in neurons, these results may suggest a possible therapeu-
tical approach using a high PUFA percentage in the diet of these patients, assuming a similar
behavior of neural cells. Other studies support the possibility that fatty acids can alter splicing
events: so, ceramides, a class of long-chain lipid fatty acids, were shown to modify the alterna-
tive splicing in different genes [31–33]; DHA, the most abundant ω-3 long-chain PUFA in
nerve cells, is particularly effective at regulating GPX4 splicing variants [34] and the liver fatty
acid desaturase alternative transcript expression [35, 36]. On the other hand, a new role for sei-
pin in brain has been proposed, and this protein seems to be involved in the mobilization of
lipids to the developing brain [15]. Lastly, studies in mice have demonstrated that dietary defi-
cit of PUFA results in alterations of nerve impulse conduction in retina, learning, and function
of the sodium potassium pump [37], accompanied by a DHA decline in membranes [38]. Fur-
thermore, supplementation with ω-3 fatty acids improves memory and learning in rats [39].
It is important to underline that seipin is a key protein in lipid droplet formation [7, 9, 40],
but no studies have deepened in the role of BSCL2 transcripts in this process. On the other
hand, others [11, 40, 41] have reported that this protein can have tissue-specific functions. In
this study, we found that during adipogenesis of adipose-derived human mesenchymal human
stem cells the skipped transcript was the most differentially expressed (>700%) compared to
the large BSCL2 transcripts, suggesting a putative and unknown role in adipogenesis. These
results apparently differ from those reported by Payne et al. [8], who found that BSCL2
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expression increased during adipogenesis in human preadipocytes since the first day; however
the lack of information about both the transcript they measured and the statistical analysis per-
formed makes difficult to interpret this apparent discrepancy with our results.
Considering the minor clinical features of generalized lipodystrophy present in homozygous
subjects for the c.985C>T mutation, it seems that Celia seipin might play some role in adipo-
cyte differentiation, besides being potentially harmful to a correct neuron function, being envi-
ronmental factors as PUFA important actors in these processes.
Finally, our results established that the mechanism of cellular senescence induction does not
alter the seipin transcripts expression and neither mutant cells exhibit a higher senescence rate,
suggesting that cellular senescence does not appear to be associated to the pathogenesis of this
new disease, on the contrary to what happens with apoptosis [42]. This agrees with the finding
that inhibitors of the ER stress significantly inhibit apoptosis, but have no effect in cell senes-
cence [43].
In summary, our study provide strong evidence that in vitro treatment with unsaturated
fatty acids reduces the expression of the Celia seipin in primary cultures of preadipocytes with
c.985C>T mutation in BSCL2 and that this mutation does not alter the rate of senescence of
these cells. We are fully aware that our paper presents a limitation that should be taken into
account. The cell model chosen, preadipocytes, does not turn out to be the most suitable to
study a process that primarily affects the central nervous system, but the difficulties to obtain
mutated human neuronal cultures are obvious. Taking into account this limitation, the results
suggest that Celia seipin might be playing a fundamental and to date unknown role in adipo-
genesis. However, the underlying molecular process whereby this intriguing transcript exert its
function remains to be elucidated as does its pathogenic mechanism.
Supporting Information
S1 Fig. Representative photographs of lipid droplets formation in ADSCs demonstrated
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